Beck Mark A 4

What Happened
Mark A. Beck, a director of Accendra Health, received a grant of 31,191 restricted common shares on 2026-05-14. The transaction is reported on a Form 4 as an award/grant (code A) with a reported acquisition price of $0.00 (total reported value $0).

Key Details

• Transaction date: 2026-05-14; Form 4 filed: 2026-05-18 (filed within the usual two-business-day window).
• Transaction type/code: Award/Grant (A). Price per share reported: $0.00.
• Shares granted: 31,191. Shares owned after the transaction: not specified in the filing.
• Footnote: These are restricted shares that vest the earlier of (i) one year from the grant date or (ii) the date of the next annual meeting that is at least 50 weeks after the grant date.

Context
Restricted stock grants are a form of compensation that vest over time per the footnote; they are not open-market purchases and do not represent an immediate cash outlay or sale. The filing shows the grant but does not assign a market value in the Form 4 (hence the $0 reported price).